Novartis wins GBCHealth Business Action on Health Award for social ventures initiative
(Thomson Reuters ONE) -
Novartis International AG /
Novartis wins GBCHealth Business Action on Health Award for social ventures
initiative
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
* GBCHealth recognizes Novartis Arogya Parivar ("Healthy Family") initiative
as one of the best corporate programs to address global health needs
* Arogya Parivar has improved access to medicine for 42 million patients
across 33,000 villages in India
* This program is a Novartis social venture, building local, sustainable
solutions to address healthcare challenges in emerging markets
Basel, Switzerland, May 17, 2013 - Novartis is pleased to announce that
GBCHealth, a coalition of more than 230 private sector companies working to
improve global health, has awarded the company's Arogya Parivar program the
Business Action on Health Award for Application of Core Competence. Arogya
Parivar is a sustainable business model that makes affordable, high-quality
medicines accessible to underserved millions in India. The program also expands
access to health education and consultations in remote villages.
"We are proud to be recognized by GBCHealth for our Arogya Parivar program,"
said Joe Jimenez, Novartis Chief Executive Officer. "Arogya Parivar is an
important part of the work Novartis is doing around the world to develop
sustainable solutions that address the unmet medical needs of people in
developing nations. Through our social ventures programs, we're making a
difference by encouraging better health and at the same time driving local
economic growth. We expect Arogya Parivar to have an enduring impact in India
and look forward to extending the model to other developing economies."
Arogya Parivar, meaning "Healthy Family" in Hindi, is a for-profit social
business developed by Novartis that adapts a market-based approach to improve
healthcare access for India's rural poor. Novartis trains health educators, who
teach communities about health and disease prevention, and sales supervisors,
who increase local medicine access across several therapeutic areas by informing
local pharmacists about products. Since launching Arogya Parivar in 2007,
Novartis has trained more than 500 health educators and supervisors and improved
access to healthcare for 42 million patients across 33,000 villages in India. As
a result of the positive impact of Arogya Parivar, Novartis is working to
further expand the social business model in 2014.
Arogya Parivar is one example of a Novartis "social venture" approach. Social
ventures build local, sustainable solutions to address healthcare challenges in
emerging markets. These programs go beyond medicine, donations, and price
reductions, by tackling larger societal issues that impact access to healthcare:
education, infrastructure and distribution. With each social venture, Novartis
adapts its approach to meet diverse local health and cultural needs. To learn
more about Novartis Social Ventures, please visit
http://www.novartis.com/corporate-responsibility/access-to-healthcare/our-key-
initiatives/index.shtml.
Disclaimer
This press release contains expressed or implied forward-looking statements,
including statements that can be identified by terminology such as "expect,"
"look forward to," or similar expressions. Such forward-looking statements
reflect the current views of the Group regarding future events, and involve
known and unknown risks, uncertainties and other factors that may cause actual
results to be materially different from any future results expressed or implied
by such statements. These expectations could be affected by, among other things,
risks and factors referred to in the Risk Factors section of Novartis AG's
current Form 20-F on file with the US Securities and Exchange Commission.
Novartis is providing the information in this press release as of this date and
does not undertake any obligation to update it in the future.
About Novartis
Novartis provides innovative healthcare solutions that address the evolving
needs of patients and societies. Headquartered in Basel, Switzerland, Novartis
offers a diversified portfolio to best meet these needs: innovative medicines,
eye care, cost-saving generic pharmaceuticals, preventive vaccines and
diagnostic tools, over-the-counter and animal health products. Novartis is the
only global company with leading positions in these areas. In 2012, the Group
achieved net sales of USD 56.7 billion, while R&D throughout the Group amounted
to approximately USD 9.3 billion (USD 9.1 billion excluding impairment and
amortization charges). Novartis Group companies employ approximately 129,000
full-time-equivalent associates and operate in more than 140 countries around
the world. For more information, please visit http://www.novartis.com.
Novartis is on Twitter. Sign up to follow (at)Novartis at
http://twitter.com/novartis.
# # #
Novartis Media Relations
Central media line : +41 61 324 2200
Eric Althoff Beth Calitri
Novartis Global Media Relations Novartis Global Media Relations
+41 61 324 7999 (direct) +41 61 324 7973 (direct)
+41 79 593 4202 (mobile) +41 79 523 0198 (mobile)
eric.althoff(at)novartis.com beth.calitri(at)novartis.com
e-mail: media.relations(at)novartis.com
For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis
For questions about the site or required registration, please contact:
journalisthelp(at)thenewsmarket.com.
Novartis Investor Relations
Central phone: +41 61 324 7944
Samir Shah +41 61 324 7944 North America:
Pierre-Michel Bringer +41 61 324 1065 Stephen Rubino +1 862 778 8301
Thomas Hungerbuehler +41 61 324 8425 Jill Pozarek +1 212 830 2445
Isabella Zinck +41 61 324 7188 Edwin Valeriano +1 212 830 2456
e-mail: investor.relations(at)novartis.com e-mail:
investor.relations(at)novartis.com
Media release (PDF):
http://hugin.info/134323/R/1702779/562710.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novartis International AG via Thomson Reuters ONE
[HUG#1702779]
Unternehmensinformation / Kurzprofil:
Datum: 17.05.2013 - 07:17 Uhr
Sprache: Deutsch
News-ID 261160
Anzahl Zeichen: 7635
contact information:
Town:
Basel
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 350 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novartis wins GBCHealth Business Action on Health Award for social ventures initiative"
steht unter der journalistisch-redaktionellen Verantwortung von
Novartis International AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
